Lassaunière R, Tiemessen CT. FcγR Genetic Variation and HIV-1 Vaccine Efficacy: Context And Considerations. Front Immunol. 2021;12:788203.
FcγR Genetic Variation and HIV-1 Vaccine Efficacy: Context And Considerations
By Content Specialist|2022-06-18T20:54:56+02:00June 18, 2022|2021 Publication, 2021: October to December|Comments Off on FcγR Genetic Variation and HIV-1 Vaccine Efficacy: Context And Considerations
Share This Story, Choose Your Platform!
About the Author: Content Specialist
Related Posts
In Utero Human Cytomegalovirus Infection Is Associated With Increased Levels of Putatively Protective Maternal Antibodies in Nonprimary Infection: Evidence for Boosting but Not Protection